Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart.
Wohlschlaeger J, Levkau B, Brockhoff G, Schmitz KJ, von Winterfeld M, Takeda A, Takeda N, Stypmann J, Vahlhaus C, Schmid C, Pomjanski N, Böcking A, Baba HA.
Wohlschlaeger J, et al. Among authors: takeda n, takeda a.
Circulation. 2010 Mar 2;121(8):989-96. doi: 10.1161/CIRCULATIONAHA.108.808071. Epub 2010 Feb 16.
Circulation. 2010.
PMID: 20159834